|
End-of-day quote
TEL AVIV STOCK EXCHANGE
10/09/2026
|
5-day change | 1st Jan Change | ||
| 1,594.00 ILa | +0.95% |
|
-4.49% | - |
| 07-14 | Rafa Laboratories Ltd. has completed an IPO in the amount of ILS 549.8718 million. | CI |
| 07-09 | Rafa Laboratories Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
TEL AVIV STOCK EXCHANGEILa
| Markets | Quality | ||
|---|---|---|---|
TEL AVIV STOCK EXCHANGE
| RAFA | End-of-day quote | |
TEL AVIV STOCK EXCHANGE
| RAFA | Delayed |
| 1 day | +0.95% | ||
| 1 week | -4.49% | ||
| Current month | -1.85% | ||
| 1 month | +8.51% |
| 1 week | 1,571 |  | 1,735 |
| 1 month | 1,401 | | 1,735 |
| Current year | 1,401 | | 1,803 |
| 1 year | 1,401 | | 1,803 |
| 3 years | 1,401 | | 1,803 |
| 5 years | 1,401 | | 1,803 |
| 10 years | 1,401 | | 1,803 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ido Leshem
CEO | Chief Executive Officer | 50 | 01/01/2024 |
Gabi Hazan
COO | Chief Operating Officer | 57 | 01/01/2007 |
Yael Paula Tomer
CTO | Chief Tech/Sci/R&D Officer | 56 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Gillon Beck
BRD | Director/Board Member | 64 | 31/12/2020 |
Abraham Dadon
BRD | Director/Board Member | 70 | 27/05/2026 |
Amir Levin
BRD | Director/Board Member | 60 | 26/06/2007 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.95% | -4.49% | - | - | 515M | |
| +2.63% | +2.10% | +53.37% | +93.96% | 994B | |
| +0.81% | -0.36% | +51.16% | +63.77% | 640B | |
| +1.74% | +5.39% | +20.49% | +70.66% | 454B | |
| +5.00% | +2.21% | +38.79% | +39.24% | 337B | |
| +1.68% | -9.20% | +16.65% | +24.87% | 261B | |
| +3.81% | +0.93% | +6.48% | +12.39% | 246B | |
| +0.65% | -3.30% | +38.56% | +44.95% | 204B | |
| +1.43% | -6.21% | -21.04% | -58.94% | 190B | |
| +1.47% | -0.62% | +29.49% | +88.38% | 178B | |
| Average | +2.00% | -5.63% | +25.99% | +42.14% | 350.53B | |
| Weighted average by Cap. | +2.18% | -4.42% | +35.17% | +57.88% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 420M 0 138M 119M 113M 102M 192M 13.21B 193M 1.35B 519M 6.7B 518M 506M 21.31B | 418M 0 137M 119M 112M 102M 191M 13.16B 192M 1.34B 517M 6.68B 516M 504M 21.23B |
| Net income | 99.43M 0 32.63M 28.27M 26.68M 24.21M 45.41M 3.13B 45.74M 319M 123M 1.59B 123M 120M 5.04B | 100M 0 32.93M 28.53M 26.92M 24.43M 45.82M 3.16B 46.15M 322M 124M 1.6B 124M 121M 5.09B |
| Net Debt | - | - |
Employees
257
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/09/26 | ILA 1,594.00 | +0.95% | 11,986 |
| 09/09/26 | ILA 1,579.00 | -5.90% | 385,717 |
| 08/09/26 | ILA 1,678.00 | -1.29% | 10,504 |
| 07/09/26 | ILA 1,700.00 | +1.86% | 1,782 |
- Stock Market
- Stocks
- RAFA Stock
Select your edition
All financial news and data tailored to specific country editions
